Does left bundle branch area pacing (LBBAP) reduce the composite of all-cause mortality, lead failure, or heart failure hospitalization compared to right ventricular pacing (RVP) in patients with atrioventricular block?
LBBAP significantly reduces the composite of mortality, lead failure, or heart failure hospitalization and improves LV systolic synchrony compared to conventional RVP in patients with AV block.
Objective: We aim to conduct a comparison of the safety and effectiveness performance between left bundle branch area pacing (LBBAP) and right ventricular pacing (RVP) regimens for patients with atrioventricular block (AVB). Methods: This observational cohort study included patients who underwent pacemaker implantations with LBBAP or RVP for AVB indications from the 1st of January 2018 to the 18th of November 2021 at West China Hospital. The primary composite outcome included all-cause mortality, lead failure, or heart failure hospitalization (HFH). The secondary outcome included periprocedure complication, cardiac death, or recurrent unexplained syncope. A 1 : 1 propensity score-matched cohort was conducted for left ventricular (LV) function analysis. Results: = 0.012). Conclusions: Compared to conventional RVP, LBBAP is a feasible novel pacing model associated with a significant reduction in the primary composite outcome. Moreover, LBBAP significantly reduces the risk of recurrent unexplained syncope and improves LV systolic synchrony. This study is registered with ClinicalTrials.gov NCT05722379.
Chen et al. (Mon,) studied this question.